【24h】

Role of implantable cardioverter defibrillator therapy in patients with acquired long QT syndrome: a long-term follow-up.

机译:植入式心脏复律除颤器治疗在获得性长QT综合征患者中的作用:长期随访。

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

AIMS: The use of implantable cardioverter defibrillators (ICD) in patients with torsade de pointes (TdP) and ventricular fibrillation in the presence of acquired long QT syndrome (aLQTS) is under debate, partly due to the fact that aLQTS is potentially reversible and currently no long-term follow-up data are available. We aimed to evaluate the long-term follow-up of patients with acquired long QT syndrome (aLQTS) who had received an implantable cardioverter defibrillator (ICD) for secondary prevention of sudden cardiac arrest (SCA). METHOD AND RESULTS: Over a 10 year period, 43 patients with an ICD after survived cardiac arrest (SCA) due to an aLQTS were included [female n= 27 (63%); mean age 61 ± 16 years]. There was no clinical evidence for congenital LQTS (Schwartz score 1.25 ± 0.8). Structural heart disease was present in 29 patients (47%; ischaemic n= 13; dilated cardiomyopathy n= 9; mean EF 41%± 12). The most common proarrhythmic trigger happened to be antiarrhythmic drugs (n= 34; 79%). Other triggers included contrast agent (n= 1), haloperidol (n= 2), severe hypokalaemia (n= 2), drug abuse/alcohol (n= 2), and mere severe bradycardia (n= 2). Under trigger QTc interval measured 536 ± 58 vs. 438 ± 33 ms without trigger (P< 0.001). During a mean follow-up of 84 ± 55 months, appropriate shocks occurred in 19 patients (44%); inappropriate shocks in 13 patients (30%; only inappropriate n= 3). Appropriate shocks were almost as common in patients without as in those with structural heart disease (35 vs. 48%; P= 0.32). None of the patients were re-exposed to the initial trigger during the follow-up period. Beta-blocker medication did not prevent ICD shocks (12 of 19 vs. 11 of 24 on medication). ConcluSION: Appropriate ICD shocks are a common finding in patients with aLQTS and SCA irrespective of the underlying cause or structural heart disease. Thus, even in the presence of relevant acquired proarrhythmia ICD may be beneficial.
机译:目的:对于存在后天性长QT综合征(aLQTS)的扭转性尖锐湿疣(TdP)和心室纤颤的患者,使用植入式心脏复律除颤器(ICD)尚在争论中,部分原因是因为aLQTS具有潜在的可逆性,目前没有长期随访数据。我们的目的是评估接受植入式心脏复律除颤器(ICD)来预防心脏骤停(SCA)的获得性长QT综合征(aLQTS)患者的长期随访情况。方法和结果:在10年的时间里,纳入了43例因aLQTS而在心脏骤停幸存(SCA)后存活的ICD患者[女性n = 27(63%);未发现异常的女性。平均年龄61±16岁]。没有先天性LQTS的临床证据(Schwartz评分1.25±0.8)。结构性心脏病存在29例(47%;缺血性n = 13;扩张型心肌病n = 9;平均EF 41%±12)。最常见的心律失常触发因素是抗心律失常药物(n = 34; 79%)。其他触发因素包括造影剂(n = 1),氟哌啶醇(n = 2),严重低钾血症(n = 2),药物滥用/酒精(n = 2)和仅严重心动过缓(n = 2)。在触发条件下,QTc间隔为536±58 vs.438±33 ms(无触发)(P <0.001)。在平均随访84±55个月期间,有19例患者(44%)发生了适当的电击。 13位患者遭受了不适当的电击(30%;仅n = 3)。在没有结构性心脏病的患者中,适当的电击几乎与在普通患者中一样常见(35比48%; P = 0.32)。在随访期间,没有患者再次暴露于最初的触发条件。 Beta受体阻滞剂不能预防ICD休克(用药19的12比24的11)。结论:适当的ICD休克是aLQTS和SCA患者的常见发现,无论其潜在病因或结构性心脏病如何。因此,即使存在相关的获得性心律失常,ICD也可能有益。

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号